Cargando…

Determinants of hypofibrinolysis in patients with digestive tract cancer

INTRODUCTION: Recently, we demonstrated that digestive tract cancer (DTC) is associated with reduced fibrin clot permeability and impaired fibrinolysis. AIM: We investigated determinants of fibrinolysis in DTC patients. MATERIAL AND METHODS: In 44 consecutive patients with DTC and 47 controls matche...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gronostaj, Katarzyna, Richter, Piotr, Nowak, Wojciech, Undas, Anetta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2016
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4916237/ https://www.ncbi.nlm.nih.gov/pubmed/27350837 http://dx.doi.org/10.5114/pg.2016.57619

Ejemplares similares

PAI-1 Overexpression in Valvular Interstitial Cells Contributes to Hypofibrinolysis in Aortic Stenosis
por: Kopytek, Magdalena, et al.
Publicado: (2023)

Hypofibrinolysis in type 2 diabetes and its clinical implications: from mechanisms to pharmacological modulation
por: Bryk-Wiązania, Agata Hanna, et al.
Publicado: (2021)

Predictors of neutrophil extracellular traps markers in type 2 diabetes mellitus: associations with a prothrombotic state and hypofibrinolysis
por: Bryk, Agata H., et al.
Publicado: (2019)

Development and application of global assays of hyper‐ and hypofibrinolysis
por: Ilich, Anton, et al.
Publicado: (2019)

More Pronounced Hypercoagulable State and Hypofibrinolysis in Patients With Cirrhosis With Versus Without HCC
por: Zanetto, Alberto, et al.
Publicado: (2021)

Hypofibrinolysis in diabetes: a therapeutic target for the reduction of cardiovascular risk
por: Kearney, Katherine, et al.
Publicado: (2017)

Plasma Fibrinogen Independently Predicts Hypofibrinolysis in Severe COVID-19
por: Schrick, Diana, et al.
Publicado: (2021)

Hypercoagulability State Combined with Post-Treatment Hypofibrinolysis in Invasive Breast Cancer: A Seven-Year Follow-Up Evaluating Disease-Free and Overall Survival
por: Wrzeszcz, Katarzyna, et al.
Publicado: (2023)

Treatment patterns for lower urinary tract symptoms and overactive bladder in an Eastern European country: a nationwide population-representative survey
por: Przydacz, Mikołaj, et al.
Publicado: (2021)

Osteonecrosis of the Jaws in Patients with Hereditary Thrombophilia/Hypofibrinolysis—From Pathophysiology to Therapeutic Implications
por: Badescu, Minerva Codruta, et al.
Publicado: (2022)

Hypofibrinolysis in pediatric patients with veno-occlusive disease in hematopoietic stem cell transplantation
por: Schneider, Veronika, et al.
Publicado: (2023)

Antithrombotic management in patients with percutaneous coronary intervention requiring oral anticoagulation
por: Zalewski, Jarosław, et al.
Publicado: (2016)

Implementation of neoadjuvant chemotherapy in muscle invasive bladder cancer treatment in Poland: a single institution retrospective study
por: Gronostaj, Katarzyna, et al.
Publicado: (2019)

Changes in neoadjuvant chemotherapy utilization in muscle invasive bladder cancer treatment: a tertiary center retrospective study
por: Gronostaj, Katarzyna, et al.
Publicado: (2020)

Association of NT-proBNP and GDF-15 with markers of a prothrombotic state in patients with atrial fibrillation off anticoagulation
por: Matusik, Paweł T., et al.
Publicado: (2019)

Case report: primary osteonecrosis associated with thrombophilia-hypofibrinolysis and worsened by testosterone therapy
por: Jarman, Michael Ian, et al.
Publicado: (2017)

Increased thrombin activatable fibrinolysis inhibitor activity is associated with hypofibrinolysis in dogs with sepsis
por: Sotos, Katherine E., et al.
Publicado: (2023)

Thrombotic Mechanism Involving Platelet Activation, Hypercoagulability and Hypofibrinolysis in Coronavirus Disease 2019
por: Wada, Hideo, et al.
Publicado: (2023)

Prevalence of genetic risk factors related with thrombophilia and hypofibrinolysis in patients with osteonecrosis of the femoral head in Poland
por: Gagala, Jacek, et al.
Publicado: (2013)

The comparison between Caprini and Padua VTE risk assessment models for hospitalised cancer patients undergoing chemotherapy at the tertiary oncology department in Poland: is pharmacological thromboprophylaxis overused?
por: Łukaszuk, Robert F., et al.
Publicado: (2018)

Non-vitamin K antagonist oral anticoagulants in cancer patients with atrial fibrillation
por: Undas, Anetta, et al.
Publicado: (2020)

How to improve the management of a patient with heparin-induced thrombocytopenia?
por: Undas, Anetta
Publicado: (2019)

Anticoagulation in Real-Life Patients with Atrial Fibrillation: Impact of Renal Disease
por: Undas, Anetta
Publicado: (2023)

Adverse outcomes in anticoagulated patients undergoing percutaneous left atrial appendage ligation
por: Undas, Anetta
Publicado: (2020)

Practical considerations on non-vitamin K oral anticoagulants in patients with high body weight
por: Undas, Anetta
Publicado: (2016)

Prothrombotic Fibrin Clot Phenotype in Patients with Deep Vein Thrombosis and Pulmonary Embolism: A New Risk Factor for Recurrence
por: Undas, Anetta
Publicado: (2017)

Sternal wound infections following cardiac surgery and their management: a single-centre study from the years 2016–2017
por: Kotnis-Gąska, Agnieszka, et al.
Publicado: (2018)

Relationship between CRP and hypofibrinolysis: Is this a possible mechanism to explain the association between CRP and outcome in critically ill patients?
por: Zouaoui Boudjeltia, Karim, et al.
Publicado: (2004)

Retinal vascular occlusion: a window to diagnosis of familial and acquired thrombophilia and hypofibrinolysis, with important ramifications for pregnancy outcomes
por: Dixon, Stephan G, et al.
Publicado: (2016)

Mixed Fibrinolytic Phenotypes in Decompensated Cirrhosis and Acute‐on‐Chronic Liver Failure with Hypofibrinolysis in Those With Complications and Poor Survival
por: Blasi, Annabel, et al.
Publicado: (2019)

Accumulation of advanced glycation end products (AGEs) is associated with the severity of aortic stenosis in patients with concomitant type 2 diabetes
por: Kopytek, Magdalena, et al.
Publicado: (2020)

Synergistic Effects of Hypofibrinolysis and Genetic and Acquired Risk Factors on the Risk of a First Venous Thrombosis
por: Meltzer, Mirjam E, et al.
Publicado: (2008)

Hypofibrinolysis induced by tranexamic acid does not influence inflammation and mortality in a polymicrobial sepsis model
por: Campos Nogueira, Yzabella Alves, et al.
Publicado: (2019)

Increased Plasma Clot Permeability and Susceptibility to Lysis Are Associated with Heavy Menstrual Bleeding of Unknown Cause: A Case-Control Study
por: Szczepaniak, Piotr, et al.
Publicado: (2015)

How to Optimize the Administration of Low-Dose Non-vitamin K Antagonist Oral Anticoagulants in Everyday Practice?
por: Undas, Anetta
Publicado: (2022)

Identification of potential prognostic factors for absence of residual disease in the second resection of T1 bladder cancer
por: Czech, Anna Katarzyna, et al.
Publicado: (2019)

Plasma Fibrin Clot Properties as Determinants of Bleeding Time in Human Subjects: Association with Histidine-Rich Glycoprotein
por: Szułdrzyński, Konstanty, et al.
Publicado: (2020)

Delayed Thrombin Generation Is Associated with Minor Bleedings in Venous Thromboembolism Patients on Rivaroxaban: Usefulness of Calibrated Automated Thrombography
por: Zalewski, Jaroslaw, et al.
Publicado: (2020)

Determination of microbiological characteristics in the digestive tract of different ruminant species
por: Zhang, Tian, et al.
Publicado: (2018)

Low fasting glucose is associated with enhanced thrombin generation and unfavorable fibrin clot properties in type 2 diabetic patients with high cardiovascular risk
por: Gajos, Grzegorz, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_j4390umkea1c711q20qjuu28kr